Extending the S-benzimidazolyl (SBiz) platform: N-alkylated SBiz glycosyl donors with the universal activation profile

Research output: Contribution to journalArticlepeer-review

Abstract

This article describes the development of alkylated S-benzimidazolyl (SBiz) imidates as versatile building blocks for chemical glycosylation. The SBiz imidates have been originally developed as a new platform for active-latent glycosylations and its utility was further extended to other common strategies for oligosaccharide synthesis. This article expands upon the utility of these compounds. We developed a general protocol for the synthesis of a series of N-alkylated SBiz glycosides from N-protected SBiz aglycones by Lewis acid-mediated coupling with glucose pentaacetate. The N-alkylated SBiz moiety was found to be stable under strong basic conditions which allowed us to obtain both armed and disarmed N-alkylated SBiz donors. These donors showed good reactivity at a variety of activation conditions, and generally provided high yields in glycosylations.
Original languageAmerican English
JournalPure and Applied Chemistry
Volume89
DOIs
StatePublished - Jan 28 2017

Keywords

  • carbohydrates; glycosylation; ICS-28; oligosaccharides; synthesis
  • carbohydrates
  • glycosylation
  • ICS-28
  • oligosaccharides
  • synthesis

Disciplines

  • Organic Chemistry
  • Biochemistry
  • Medical Biochemistry

Cite this